We are live on ! Find out more
WA

WuXi AppTec Portfolio holdings

AUM $19M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+27.45%
1 Year Est. Return
+20.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$38.6M
AUM Growth
–
Cap. Flow
+$32.8M
Cap. Flow %
85.05%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LYEL icon
Lyell Immunopharma
LYEL
+$14.7M
2
AMAM
Ambrx Biopharma Inc
AMAM
+$11.4M
3
ADAG
Adagene
ADAG
+$6.38M
4
PPBT
Purple Biotech
PPBT
+$215K
5
CSTL icon
Castle Biosciences
CSTL
+$117K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYEL icon
1
Lyell Immunopharma
LYEL
$317M
$15.9M 41.15%
+409,034
New +$14.7M
AMAM
2
DELISTED
Ambrx Biopharma Inc
AMAM
$14.2M 36.92%
+1,000,000
New +$11.4M
ADAG
3
Adagene
ADAG
$248M
$8.16M 21.16%
+4,225,696
New +$6.38M
PPBT
4
Purple Biotech
PPBT
$1.31M
$151K 0.39%
+971
New +$215K
CSTL icon
5
Castle Biosciences
CSTL
$849M
$143K 0.37%
+6,636
New +$117K

Similar funds

TOTSC
Trustees of the Smith College Northampton, Massachusetts $18.3M AUM 20.14% 1-Year Est. Return
RPA
Rose Park Advisors Boston, Massachusetts $17.5M AUM 44.41% 1-Year Est. Return
SIIG
SC Israel IV Genpar Herzelia, Israel $17.5M AUM
UID
Union Investments & Development Tel Aviv, Israel $17.3M AUM 20.08% 1-Year Est. Return
OCM
Oakview Capital Management Dallas, Texas $21.6M AUM 20.25% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
CMG
Cavalry Management Group San Francisco, California $22.3M AUM 65.95% 1-Year Est. Return

WuXi AppTec's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for WuXi AppTec, which disclosed 5 positions worth $38.6M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Lyell Immunopharma: 409,034 shares worth $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • WuXi AppTec's largest Q4 2023 buy was Lyell Immunopharma: 409,034 shares worth $15.9M.
  • WuXi AppTec's ten largest holdings make up 100% of its $38.6M portfolio in Q4 2023.
  • WuXi AppTec disclosed 5 positions in Q4 2023, its first 13F filing on record.

Based on WuXi AppTec's 13F filing for Q4 2023, filed 6 Feb 2024.